Immune system disorder

Part of

Sub-types of Immune system disorder

• Autoimmune disease 315 trials · 4,049 incl. sub-types
  47 sub-types

  • Autoimmune disorder of the nervous system 47 trials · 1,067 incl. sub-types Sub-types →
  • Autoimmune disorder of gastrointestinal tract 0 trials · 942 incl. sub-types Sub-types →
  • Autoimmune disorder of endocrine system 1 trial · 929 incl. sub-types Sub-types →
  • CNS demyelinating autoimmune disease 5 trials · 859 incl. sub-types Sub-types →
  • Autoimmune disorder of musculoskeletal system 0 trials · 797 incl. sub-types Sub-types →
  • Lupus erythematosus 40 trials · 551 incl. sub-types Sub-types →
  • Scleroderma 47 trials · 305 incl. sub-types Sub-types →
  • Autoimmune disorder of exocrine system 0 trials · 197 incl. sub-types Sub-types →
  • Autoimmune disorder of blood 0 trials · 152 incl. sub-types Sub-types →
  • Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types Sub-types →
  • Vitiligo 100 trials Sub-types →
  • Antiphospholipid syndrome 58 trials · 59 incl. sub-types Sub-types →
  • Autoimmune bullous skin disease 7 trials · 56 incl. sub-types Sub-types →
  • Immunoglobulin G4-related sclerosing disease 30 trials · 34 incl. sub-types Sub-types →
  • Rheumatic fever 17 trials
  • Overlapping connective tissue disease 2 trials · 15 incl. sub-types Sub-types →
  • Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types Sub-types →
  • Undifferentiated connective tissue syndrome 7 trials
  • Autoimmune pulmonary alveolar proteinosis 6 trials
  • Type III hypersensitivity disease 3 trials · 6 incl. sub-types Sub-types →
  • Anti-glomerular basement membrane disease 5 trials
  • Autoimmune disease of ear, nose and throat 0 trials · 4 incl. sub-types Sub-types →
  • Autoimmune disorder of cardiovascular system 0 trials · 3 incl. sub-types Sub-types →
  • Cryoglobulinemia 3 trials Sub-types →
  • Susac syndrome 2 trials
  • Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types Sub-types →
  • Anti-neutrophil antibody associated vasculitis 1 trial
  • Phacolytic glaucoma 1 trial
  • Secondary neonatal autoimmune disease 0 trials · 1 incl. sub-types Sub-types →
  • Jaccoud syndrome 0 trials
  • Kimura disease 0 trials
  • Reynolds syndrome 0 trials
  • Autoerythrocyte sensitization syndrome 0 trials
  • Autoimmune disease with susceptibility to mycobacterium tuberculosis 0 trials
  • Autoimmune glomerulonephritis 0 trials
  • Autoimmune pulmonary disease due to PD-1 deficiency 0 trials
  • Autoimmune urticaria 0 trials
  • Euthyroid Graves orbitopathy 0 trials
  • Multisystem autoimmune disease due to IKAROS gain of function 0 trials
  • Non-specific autoimmune brainstem encephalitis with characteristic antibodies 0 trials
  • Non-specific autoimmune brainstem encephalitis without characteristic antibodies 0 trials
  • Non-specific autoimmune cerebellar ataxia with characteristic antibodies 0 trials
  • Non-specific autoimmune cerebellar ataxia without characteristic antibodies 0 trials
  • Non-specific autoimmune supratentorial encephalitis with characteristic antibodies 0 trials
  • Non-specific autoimmune supratentorial encephalitis without characteristic antibodies 0 trials
  • Tempi syndrome 0 trials
  • Type II hypersensitivity reaction disease 0 trials
• Leukocyte disorder 6 trials · 3,581 incl. sub-types
  23 sub-types

  • B-cell neoplasm 305 trials · 3,174 incl. sub-types Sub-types →
  • T-cell leukemia 9 trials · 137 incl. sub-types Sub-types →
  • B cell deficiency 5 trials · 86 incl. sub-types Sub-types →
  • Leukopenia 6 trials · 78 incl. sub-types Sub-types →
  • Dendritic cell sarcoma 0 trials · 53 incl. sub-types Sub-types →
  • Eosinophil disorder 2 trials · 51 incl. sub-types Sub-types →
  • Langerhans cell histiocytosis 40 trials · 41 incl. sub-types Sub-types →
  • Phagocyte bactericidal dysfunction 0 trials · 37 incl. sub-types Sub-types →
  • Mastocytosis 15 trials · 34 incl. sub-types Sub-types →
  • Functional neutrophil defect 0 trials · 13 incl. sub-types Sub-types →
  • Mast cell activation syndrome 8 trials · 9 incl. sub-types Sub-types →
  • POEMS syndrome 8 trials
  • Subcutaneous panniculitis-like T-cell lymphoma 8 trials
  • EBV-positive T-cell lymphoproliferative disorder of childhood 3 trials · 7 incl. sub-types Sub-types →
  • Thymoma type B 0 trials · 4 incl. sub-types Sub-types →
  • Human granulocytic anaplasmosis 1 trial
  • Pelger-Huet anomaly 0 trials
  • Eosinophil peroxidase deficiency 0 trials
  • Hereditary neutrophilia 0 trials
  • Human monocytic ehrlichiosis 0 trials
  • Leukostasis 0 trials
  • Pituitary gland basophil adenoma 0 trials
  • Small intestinal enteropathy-associated T-cell lymphoma 0 trials
• Immune system cancer 0 trials · 3,127 incl. sub-types
  25 sub-types

  • Bone marrow cancer 2 trials · 1,633 incl. sub-types Sub-types →
  • Plasma cell myeloma 1,108 trials · 1,131 incl. sub-types Sub-types →
  • Thymus cancer 10 trials · 225 incl. sub-types Sub-types →
  • Primary central nervous system lymphoma 92 trials · 103 incl. sub-types Sub-types →
  • Lymphatic system cancer 4 trials · 70 incl. sub-types Sub-types →
  • Dendritic cell sarcoma 0 trials · 53 incl. sub-types Sub-types →
  • B-cell childhood acute lymphoblastic leukemia 37 trials
  • T-cell childhood acute lymphocytic leukemia 10 trials
  • Waldeyer's ring cancer 0 trials · 8 incl. sub-types Sub-types →
  • Subcutaneous panniculitis-like T-cell lymphoma 8 trials
  • Primary vitreoretinal large b-cell lymphoma 3 trials
  • Indolent primary cutaneous B-cell lymphoma 1 trial · 2 incl. sub-types Sub-types →
  • Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood 2 trials
  • Breast diffuse large B-cell lymphoma 1 trial
  • Colon Burkitt lymphoma 0 trials
  • Colorectal diffuse large B-cell lymphoma 0 trials
  • Gastric mantle cell lymphoma 0 trials
  • Liver diffuse large B-cell lymphoma 0 trials
  • Mast cell sarcoma 0 trials
  • Primary pulmonary diffuse large B-cell lymphoma 0 trials
  • Small intestinal Burkitt lymphoma 0 trials
  • Small intestinal diffuse large B-cell lymphoma 0 trials
  • Small intestinal enteropathy-associated T-cell lymphoma 0 trials
  • Solitary plasmacytoma of chest wall 0 trials
  • Thyroid gland diffuse large B-cell lymphoma 0 trials
• Bone marrow disorder 18 trials · 1,763 incl. sub-types
  7 sub-types

  • Bone marrow neoplasm 3 trials · 1,633 incl. sub-types Sub-types →
  • Polycythemia 9 trials · 99 incl. sub-types Sub-types →
  • Bone marrow failure syndrome 48 trials Sub-types →
  • Osteomyelitis 43 trials · 46 incl. sub-types Sub-types →
  • Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
  • Drachtman Weinblatt Sitarz syndrome 0 trials
  • Premature ovarian failure 15 0 trials
• Inflammatory bowel disease 430 trials · 1,081 incl. sub-types
  40 sub-types

  • Colitis 41 trials · 679 incl. sub-types Sub-types →
  • Crohn disease 563 trials · 569 incl. sub-types Sub-types →
  • Proctitis 2 trials · 21 incl. sub-types Sub-types →
  • Inflammatory bowel disease 1 3 trials
  • Undetermined colitis 3 trials
  • Ulcerative proctosigmoiditis 2 trials
  • ALPI-related inflammatory bowel disease 0 trials
  • IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
  • TRIM22-related inflammatory bowel disease 0 trials
  • Cap polyposis 0 trials
  • Cutaneous photosensitivity-lethal colitis syndrome 0 trials
  • Inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessive 0 trials
  • Inflammatory bowel disease 10 0 trials
  • Inflammatory bowel disease 11 0 trials
  • Inflammatory bowel disease 12 0 trials
  • Inflammatory bowel disease 13 0 trials
  • Inflammatory bowel disease 14 0 trials
  • Inflammatory bowel disease 15 0 trials
  • Inflammatory bowel disease 16 0 trials
  • Inflammatory bowel disease 17 0 trials
  • Inflammatory bowel disease 18 0 trials
  • Inflammatory bowel disease 19 0 trials
  • Inflammatory bowel disease 2 0 trials
  • Inflammatory bowel disease 20 0 trials
  • Inflammatory bowel disease 21 0 trials
  • Inflammatory bowel disease 22 0 trials
  • Inflammatory bowel disease 23 0 trials
  • Inflammatory bowel disease 24 0 trials
  • Inflammatory bowel disease 26 0 trials
  • Inflammatory bowel disease 27 0 trials
  • Inflammatory bowel disease 29 0 trials
  • Inflammatory bowel disease 3 0 trials
  • Inflammatory bowel disease 30 0 trials
  • Inflammatory bowel disease 4 0 trials
  • Inflammatory bowel disease 5 0 trials
  • Inflammatory bowel disease 6 0 trials
  • Inflammatory bowel disease 7 0 trials
  • Inflammatory bowel disease 8 0 trials
  • Inflammatory bowel disease 9 0 trials
  • Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
• Hypersensitivity reaction disease 32 trials · 1,025 incl. sub-types
  10 sub-types

  • Allergic disease 179 trials · 969 incl. sub-types Sub-types →
  • Anaphylaxis 26 trials · 27 incl. sub-types Sub-types →
  • Type IV hypersensitivity disease 0 trials · 18 incl. sub-types Sub-types →
  • Hypersensitivity vasculitis 0 trials · 16 incl. sub-types Sub-types →
  • Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
  • IgE responsiveness, atopic 9 trials
  • Type III hypersensitivity disease 3 trials · 6 incl. sub-types Sub-types →
  • Progestogen hypersensitivity 3 trials
  • Pseudoallergy 0 trials Sub-types →
  • Type II hypersensitivity reaction disease 0 trials
• Immunodeficiency disease 55 trials · 779 incl. sub-types
  95 sub-types

  • T-cell immunodeficiency 4 trials · 484 incl. sub-types Sub-types →
  • B cell deficiency 5 trials · 86 incl. sub-types Sub-types →
  • Myalgic encephalomeyelitis/chronic fatigue syndrome 75 trials
  • Combined immunodeficiency 3 trials · 57 incl. sub-types Sub-types →
  • Complement deficiency 2 trials · 28 incl. sub-types Sub-types →
  • X-linked lymphoproliferative syndrome 7 trials · 11 incl. sub-types Sub-types →
  • GATA2 deficiency with susceptibility to MDS/AML 5 trials · 8 incl. sub-types Sub-types →
  • Idiopathic CD4 lymphocytopenia 7 trials
  • IKBKG-related immunodeficiency with or without ectodermal dysplasia 0 trials · 4 incl. sub-types Sub-types →
  • Immunodeficiency due to selective anti-polysaccharide antibody deficiency 2 trials
  • IRF4-related immune disorder 1 trial Sub-types →
  • PTEN harmartoma tumor syndrome with immune disorder 1 trial
  • Immunodeficiency 23 1 trial
  • Immunodeficiency 31B 1 trial
  • DNAJC21-related Shwachman Diamond syndrome 0 trials
  • DOCK2 deficiency 0 trials
  • FADD-related immunodeficiency 0 trials
  • FASLG-related immunodeficiency 0 trials
  • FNIP1-associated syndrome 0 trials
  • Shwachman-Diamond syndrome 1 0 trials
  • TFRC-related combined immunodeficiency 0 trials
  • TNFRSF9-related immunodeficiency 0 trials Sub-types →
  • Wiskott-Aldrich syndrome 2 0 trials
  • Wiskott-Aldrich syndrome, autosomal dominant form 0 trials
  • Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome 0 trials
  • Chronic mucocutaneous candidiasis and connective tissue disease due to JNK1 haploinsufficiency 0 trials
  • Cryptosporidiosis-chronic cholangitis-liver disease syndrome 0 trials
  • Hatipoglu immunodeficiency syndrome 0 trials
  • Hypoproteinemia, hypercatabolic 0 trials
  • Immune deficiency due to impaired neutrophil phagocytosis and migration 0 trials
  • Immunodeficiency 101 (varicella zoster virus-specific) 0 trials
  • Immunodeficiency 102 0 trials
  • Immunodeficiency 106, susceptibility to viral infections 0 trials
  • Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection 0 trials
  • Immunodeficiency 112 0 trials
  • Immunodeficiency 113 with autoimmunity and autoinflammation 0 trials
  • Immunodeficiency 114, folate-responsive 0 trials
  • Immunodeficiency 115 with autoinflammation 0 trials
  • Immunodeficiency 117 0 trials
  • Immunodeficiency 118 0 trials
  • Immunodeficiency 119 0 trials
  • Immunodeficiency 11b with atopic dermatitis 0 trials
  • Immunodeficiency 121 with autoinflammation 0 trials
  • Immunodeficiency 122 0 trials
  • Immunodeficiency 123 with HPV-related verrucosis 0 trials
  • Immunodeficiency 125 0 trials
  • Immunodeficiency 126, susceptibility to 0 trials
  • Immunodeficiency 127 0 trials
  • Immunodeficiency 128 0 trials
  • Immunodeficiency 132b 0 trials
  • Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy 0 trials
  • Immunodeficiency 134 (Epstein-Barr virus-specific) 0 trials
  • Immunodeficiency 14b, autosomal recessive 0 trials
  • Immunodeficiency 15a 0 trials
  • Immunodeficiency 35 0 trials
  • Immunodeficiency 45 0 trials
  • Immunodeficiency 53 0 trials
  • Immunodeficiency 57 0 trials
  • Immunodeficiency 60 0 trials
  • Immunodeficiency 62 0 trials
  • Immunodeficiency 63 with lymphoproliferation and autoimmunity 0 trials
  • Immunodeficiency 64 0 trials
  • Immunodeficiency 65, susceptibility to viral infections 0 trials
  • Immunodeficiency 66 0 trials
  • Immunodeficiency 67 0 trials
  • Immunodeficiency 69 0 trials
  • Immunodeficiency 70 0 trials
  • Immunodeficiency 72 with autoinflammation 0 trials
  • Immunodeficiency 74, COVID-19-related, X-linked 0 trials
  • Immunodeficiency 75 0 trials
  • Immunodeficiency 76 0 trials
  • Immunodeficiency 77 0 trials
  • Immunodeficiency 78 with autoimmunity and developmental delay 0 trials
  • Immunodeficiency 80 with or without congenital cardiomyopathy 0 trials
  • Immunodeficiency 81 0 trials
  • Immunodeficiency 82 with systemic inflammation 0 trials
  • Immunodeficiency 84 0 trials
  • Immunodeficiency 85 and autoimmunity 0 trials
  • Immunodeficiency 86 0 trials
  • Immunodeficiency 87 and autoimmunity 0 trials
  • Immunodeficiency 88 0 trials
  • Immunodeficiency 89 and autoimmunity 0 trials
  • Immunodeficiency 91 and hyperinflammation 0 trials
  • Immunodeficiency 92 0 trials
  • Immunodeficiency 93 and hypertrophic cardiomyopathy 0 trials
  • Immunodeficiency 95 0 trials
  • Immunodeficiency 96 0 trials
  • Immunodeficiency 97 with autoinflammation 0 trials
  • Immunodeficiency 98 with autoinflammation, X-linked 0 trials
  • Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias 0 trials
  • Immunodeficiency due to CD25 deficiency 0 trials
  • Lymphoproliferative syndrome 1 0 trials
  • Primary immunodeficiency due to calcium channel deficiency 0 trials
  • Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency 0 trials
  • Pyogenic bacterial infections due to MyD88 deficiency 0 trials
• Lymphoid system disorder 1 trial · 749 incl. sub-types
  5 sub-types

  • Lymphatic system disorder 31 trials · 711 incl. sub-types Sub-types →
  • Tonsillitis 23 trials · 28 incl. sub-types Sub-types →
  • Waldeyer's ring cancer 0 trials · 8 incl. sub-types Sub-types →
  • Tonsil neoplasm 0 trials · 8 incl. sub-types Sub-types →
  • Peritonsillar abscess 4 trials
• Psoriasis 381 trials
  3 sub-types

  • Pustular psoriasis 6 trials · 39 incl. sub-types Sub-types →
  • Guttate psoriasis 2 trials
  • Psoriasis 2 0 trials
• Inborn error of immunity 121 trials · 345 incl. sub-types
  40 sub-types

  • Lymphoproliferative syndrome 70 trials · 100 incl. sub-types Sub-types →
  • B cell deficiency 5 trials · 86 incl. sub-types Sub-types →
  • Phagocyte bactericidal dysfunction 0 trials · 37 incl. sub-types Sub-types →
  • Complement deficiency 2 trials · 28 incl. sub-types Sub-types →
  • Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
  • Aicardi-Goutieres syndrome 9 trials Sub-types →
  • Familial isolated congenital asplenia 6 trials
  • Chronic mucocutaneous candidiasis 4 trials Sub-types →
  • Immunoglobulin heavy chain deficiency 0 trials · 2 incl. sub-types Sub-types →
  • A20 haploinsufficiency 1 trial
  • BENTA disease 1 trial
  • Immuno-osseous dysplasia 0 trials · 1 incl. sub-types Sub-types →
  • Immunodysregulation with variable immunodeficiency and autoimmunity 1 trial
  • IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
  • NK cell deficiency 0 trials
  • Say-Barber-Miller syndrome 0 trials
  • T cell and NK cell immunodeficiency 0 trials
  • T-cell immunodeficiency with epidermodysplasia verruciformis 0 trials
  • X-linked immunoneurologic disorder 0 trials
  • Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0 trials
  • Combined immunodeficiency due to moesin deficiency 0 trials
  • Combined immunodeficiency with faciooculoskeletal anomalies 0 trials
  • Dendritic cell deficiency 0 trials
  • Ectodermal dysplasia and immune deficiency 0 trials Sub-types →
  • Hepatic veno-occlusive disease-immunodeficiency syndrome 0 trials
  • Immune dysregulation with immunodeficiency due to AIOLOS haploinsufficiency 0 trials
  • Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome 0 trials
  • Immunodeficiency 28 0 trials
  • Immunodeficiency 33 0 trials
  • Immunodeficiency 37 0 trials Sub-types →
  • Immunodeficiency 39 0 trials
  • Immunodeficiency 47 0 trials
  • Immunodeficiency 49 0 trials
  • Immunodeficiency with defective T-cell response to interleukin 1 0 trials
  • Immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein 0 trials
  • Inflammatory bowel disease-recurrent sinopulmonary infections syndrome 0 trials
  • Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 0 trials
  • Properdin deficiency, X-linked 0 trials
  • Recurrent infections associated with rare immunoglobulin isotypes deficiency 0 trials
  • Trichohepatoenteric syndrome 0 trials Sub-types →
• Graft versus host disease 186 trials · 300 incl. sub-types
  2 sub-types

  • Chronic graft versus host disease 118 trials
  • Acute graft versus host disease 86 trials
• Thymus gland disorder 1 trial · 240 incl. sub-types
  3 sub-types

  • Thymus neoplasm 5 trials · 240 incl. sub-types Sub-types →
  • Ectopic thymus 0 trials
  • Thymic dysplasia 0 trials
• Spondyloarthropathy 122 trials · 199 incl. sub-types
  3 sub-types

  • Ankylosing spondylitis 110 trials · 114 incl. sub-types Sub-types →
  • Kummell disease 1 trial
  • Hypermobility of coccyx 0 trials
• Thrombocytopenic purpura 8 trials · 116 incl. sub-types
  2 sub-types

  • Autoimmune thrombocytopenic purpura 95 trials
  • Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types Sub-types →
• Granulomatosis with polyangiitis 95 trials · 115 incl. sub-types
  1 sub-type

  • Eosinophilic granulomatosis with polyangiitis 33 trials
• Phagocytic cell dysfunction 1 trial · 77 incl. sub-types
  7 sub-types

  • Langerhans cell histiocytosis 40 trials · 41 incl. sub-types Sub-types →
  • Defective phagocytic cell engulfment 0 trials · 37 incl. sub-types Sub-types →
  • Phagocyte bactericidal dysfunction 0 trials · 37 incl. sub-types Sub-types →
  • Defective phagocytic cell chemotaxis 0 trials
  • Defective phagocytic cell opsonization 0 trials
  • Familial lipochrome histiocytosis 0 trials
  • Phagocytosis, plasma-related defect 1N 0 trials
• Cytokine release syndrome 33 trials
• Immunoproliferative disorder 19 trials
• T-cell large granular lymphocyte leukemia 18 trials
• Familial Mediterranean fever 15 trials
  2 sub-types

  • Autosomal recessive familial Mediterranean fever 0 trials
  • Familial Mediterranean fever, autosomal dominant 0 trials
• Immunodeficiency-related disorder 1 trial · 15 incl. sub-types
  1 sub-type

  • AIDS-related disorder 3 trials · 14 incl. sub-types Sub-types →
• Twin to twin transfusion syndrome 14 trials
  1 sub-type

  • Twin reversal arterial perfusion syndrome 1 trial
• 22q11.2 deletion syndrome 7 trials · 13 incl. sub-types
  4 sub-types

  • DiGeorge syndrome 11 trials
  • Velocardiofacial syndrome 4 trials
  • Chromosome 22q11.2 deletion syndrome, distal 0 trials
  • Congenital unilateral hypoplasia of depressor anguli oris 0 trials
• Immune reconstitution inflammatory syndrome 11 trials
• Cryopyrin-associated periodic syndrome 10 trials
  3 sub-types

  • CINCA syndrome 4 trials
  • Muckle-Wells syndrome 3 trials
  • Familial cold autoinflammatory syndrome 3 trials Sub-types →
• Acquired immunodeficiency 5 trials
  2 sub-types

  • Good syndrome 0 trials
  • Acquired adult-onset immunodeficiency 0 trials
• TNF receptor 1-associated periodic fever syndrome 4 trials
• Anti-HLA hyperimmunization 3 trials
• Hyperimmunoglobulinemia D with periodic fever 2 trials
• Proteosome-associated autoinflammatory syndrome 2 trials
  6 sub-types

  • Proteasome-associated autoinflammatory syndrome 1 1 trial
  • Proteasome-associated autoinflammatory syndrome 2 0 trials
  • Proteasome-associated autoinflammatory syndrome 3 0 trials
  • Proteasome-associated autoinflammatory syndrome 4 0 trials
  • Proteasome-associated autoinflammatory syndrome 5 0 trials
  • Proteasome-associated autoinflammatory syndrome 6 0 trials
• Roifman syndrome 1 trial
• Aggressive insulitis 1 trial
• Growth hormone insensitivity with immune dysregulation 1, autosomal recessive 1 trial
• Transcobalamin II deficiency 1 trial
• CADINS disease 0 trials
• Vici syndrome 0 trials
• Autoinflammation, panniculitis, and dermatosis syndrome 0 trials
  2 sub-types

  • Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant 0 trials
  • Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive 0 trials
• Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
• Autosomal recessive osteopetrosis 7 0 trials
• Benign insulitis 0 trials
• Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0 trials
• Cytokine receptor deficiency 0 trials
• Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome 0 trials
• Epidermodysplasia verruciformis 0 trials
  1 sub-type

  • Epidermodysplasia verruciformis, X-linked 0 trials
• Erythroderma desquamativum 0 trials
• Immune system organ benign neoplasm 0 trials
  3 sub-types

  • Benign neoplasm of lymph node 0 trials
  • Benign neoplasm of spleen 0 trials Sub-types →
  • Benign neoplasm of thymus 0 trials Sub-types →
• Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials